Skip to main content
IMBdx, Inc. logo

IMBdx, Inc. — Investor Relations & Filings

Ticker · 461030 ISIN · KR7461030009 KO Human health and social work activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 461030

About IMBdx, Inc.

https://www.imbdx.com/eng/

IMBdx, Inc. is a precision oncology company specializing in liquid biopsy technology for cancer care. The company develops and provides diagnostic solutions that analyze genomic and epigenomic profiles of circulating tumor DNA (ctDNA) from a single blood draw. Its core technology, the AlphaLiquid platform, offers a suite of products for various clinical applications across the full continuum of cancer care. These applications include early-stage cancer screening (CancerFind), diagnosis, treatment selection through comprehensive genomic profiling (AlphaLiquid), and monitoring for recurrence (CancerDetect). The minimally-invasive tests are designed to provide safe, accurate, and personalized information to guide treatment decisions and improve patient outcomes.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period January 1, 2026 to March 31, 2026 (제09기). It contains detailed financial statements, business overview, risk management disclosures, and other substantive financial data, matching the definition of an Interim/Quarterly Report. Therefore, the correct classification is IR. Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a public disclosure of the results of the regular shareholders’ meeting (정기주주총회 결과), listing each agenda item, vote outcomes, approval rates, director elections, and related shareholder meeting details. This corresponds to Official Voting Results from a general meeting rather than the presentation materials or the full report itself. Therefore, it should be classified as a Declaration of Voting Results & Voting Rights announcement.
2026-03-30 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 98% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'IMBDx' (주식회사 아이엠비디엑스). It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements for the fiscal year ending December 31, 2025. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis (MD&A) or business overview typically found in a full 10-K, and it is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2025
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 99% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion, key financial data, and auditor information for the fiscal year ending 2025-12-31. While it contains financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it falls under the category of Audit Report / Information (AR). FY 2025
2026-03-20 Korean
[기재정정]주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (IMBDx) regarding the exercise of stock options (주식매수선택권행사). It is a correction report (정정신고) updating the expected listing date of new shares resulting from these options. This falls under the category of share issuance or capital changes, specifically related to stock option exercises, which is classified as 'SHA' (Share Issue/Capital Change).
2026-03-16 Korean
[기재정정]주식매수선택권행사
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from the company '아이엠비디엑스' (IMBDX) regarding the exercise of stock options (주식매수선택권행사). It is a correction filing (정정신고) updating the scheduled listing date for new shares. This type of filing, which details the issuance of new shares resulting from stock option exercises and changes in capital structure, falls under the category of 'Share Issue/Capital Change'.
2026-03-13 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.